RxDoctor Payments Data

Taylor Hamby

Family · Greenville, SCNPI 1013795822

Payments from drug & device makers

$2,848in general payments, 2019–2025

Across 156 payments — averaging $18.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$660
  • AbbVie$628
  • Lilly USA, LLC$213
  • Novo Nordisk$204
  • Bayer$186
  • Pfizer$147
  • plus $810 from 17 others

What the payments were for

  • Food & beverage$2,848100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,848 in reported general payments places this provider in the 85th percentile of 3,248 family providers in South Carolina.

See all family providers in South Carolina

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol53$45,930
OzempicSemaglutide36$40,278
Trelegy ElliptaFluticasone/Umeclidin/Vilanter43$35,606
Breztri AerosphereBudesonide/Glycopyr/Formoterol27$29,135
EliquisApixaban19$21,130
MounjaroTirzepatide19$19,988
JardianceEmpagliflozin12$15,566
MyrbetriqMirabegron15$11,794
Albuterol Sulfate HfaAlbuterol Sulfate128$3,863
Lantus SolostarInsulin Glargine,hum.Rec.Anlog17$2,454
Gabapentin80$1,449
Esomeprazole Magnesium12$1,354
Fluticasone Propionate113$1,238
Lubiprostone14$1,216
Atorvastatin Calcium138$1,187

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga, Breztri Aerosphere$660$75,06480 claims
Novo NordiskOzempic$204$40,27836 claims
GSKTrelegy Ellipta$128$35,60643 claims
PfizerEliquis$147$21,13019 claims
Lilly USA, LLCMounjaro$213$19,98819 claims
Boehringer IngelheimJardiance$69$15,56612 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,248 family providers in South Carolina.

Other family in Greenville

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →